Syövänhoidon vastuualue

Julkaisut 2017
Publications 2017

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Ali AS et al. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
2 Aula H et al. Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.
3 Boman E et al. Importance of deformable image registration and biological dose summation in planning of radiotherapy retreatments.
4 Boman E et al. The robustness of dual isocenter VMAT radiation therapy for bilateral lymph node positive breast cancer.
5 Boman E et al. The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments.
6 Cohen R et al. Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and perspectives.
7 Ducreux M et al. Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer -A definite conclusion?
8 Forsgård R et al. Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.
9 Fortner R et al. Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.
10 Guren T et al. Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.
11 Hietanen T. The Effects of Irradiation, Hyper-, and Hypothermia on Viability and Cytotoxicity of Natural Killer Cells.
12 Hippeläinen E et al. Ejection fraction in myocardial perfusion imaging assessed with a dynamic phantom: comparison between IQ-SPECT and LEHR.
13 Joensuu H et al. Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
14 Kaartinen I et al. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
15 Kallio J et al. Resistin and interleukin-6 as predictive factors for recurrence and long-term prognosis in renal cell .
16 Kapanen M et al. Effects of multiple breath hold reproducibility on treatment localization and dosimetric accuracy in radiotherapy of left-sided breast cancer with voluntary deep inspiration breath hold technique.
17 Korkeila E et al. Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.
18 Lehto J et al. Undergraduate curriculum in palliative medicine at Tampere University increases students' knowledge.
19 Lemma S et al. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
20 Mäkitie A et al. Head and neck cancer management in the Nordic countries: an effort to harmonize treatment.
21 Niemelä J et al. Measurement and properties of the dose-area product ratio in external small-beam radiotherapy.
22 Orell-Kotikangas H et al. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients.
23 Partanen M et al. Comparison of two Monte Carlo-based codes for small-field dose calculations in external beam radiotherapy.
24 Rajala K et al. mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis.
25 Saukkonen M et al. Syöpäpotilaan ja hänen läheisensä selviytymistä edistävät tekijät palliatiivisen hoidon aikana.
26 Seppälä J et al. Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
27 Sormunen J et al. Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes.
28 Sunela K. Follikulaarisen lymfooman nykyhoito.
29 Sunela K. Luganon 14. kansainvälinen lymfoomakonferenssi.
30 Tiirola A et al. End-of-Life Care of Patients With Amyotrophic Lateral Sclerosis and Other Nonmalignant Diseases.
31 Trovik C et al. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.
32 Tuohinen S et al. Detection of early radiotherapy-induced changes in intrinsic myocardial contractility by ultrasound tissue characterization in patients with early-stage breast cancer.
33 Tuohinen S et al. Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: speckle tracking echocardiography study.
34 Turcotte M et al. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
35 Väänänen T et al. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
36 Winther S et al. Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.
37 Wu X et al. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
38 Wu X et al. The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy.
39 Wu X et al. Correlation between apparent diffusion coefficient value on diffusion weighted MR imaging and Gleason score in prostate cancer.
40 Ålgars A et al. EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.

Julkaisutietokanta 20.6.2018 Publications Data Base 20.6.2018